(±)-Sotalol-d7 HCl (iso-propyl-d7)

(±)-Sotalol-d7 HCl (iso-propyl-d7) is a deuterium-labeled form of the drug Sotalol Hydrochloride, which is a beta-blocker medication used to treat arrhythmias (abnormal heart rhythms) and hypertension (high blood pressure). The deuterium-labeled form is used in laboratory settings for research purposes, including drug metabolism studies and pharmacokinetic analyses. Chemically, (±)-Sotalol-d7 HCl (iso-propyl-d7) is a hydrochloride salt of Sotalol, with seven deuterium atoms incorporated into its isopropyl side chain. It has a molecular weight of 308.86 g/mol and a molecular formula of C12H21D7ClN2O3. The deuterium-labeled compound is synthesized through a multistep process involving the incorporation of deuterium atoms into specific positions in the molecule. The usage of (±)-Sotalol-d7 HCl (iso-propyl-d7) is primarily focused on scientific research, including drug metabolism studies and pharmacokinetic analyses. It is used to study the metabolic pathways of Sotalol and its interactions with other drugs, as well as to investigate the pharmacokinetics of the drug in various animal models. In conclusion, (±)-Sotalol-d7 HCl (iso-propyl-d7) is a deuterium-labeled form of the drug Sotalol Hydrochloride, primarily used in laboratory settings for scientific research purposes. Its chemical properties allow it to be used in drug metabolism studies and pharmacokinetic analyses, making it a valuable tool in the development of new drugs and treatments for cardiovascular diseases.